MANAGING LOCALLY ADVANCED CERVICAL CARCINOMA WITH A PELVIC KIDNEY USING VOLUMETRIC MODULATED ARC THERAPY: A CLINICAL CHALLENGE

The coexistence of cervical carcinoma and pelvic kidney is uncommon. Given that the pelvic kidney occupies the traditional radiation field for cervical carcinoma, treating these patients with radiation poses a therapeutic dilemma. We report the case of a 72 years old patient with stage IIIB cervical carcinoma with an incidental diagnosis of pelvic kidney was treated with radical chemoradiotherapy using volumetric-modulated arctherapy with concurrent weekly cisplatin.. At the 12-month follow-up, the patient was disease free and had no deterioration in kidney function. Volumetric-modulated arc therapy (VMAT) allowed for the precise delivery of high radiation doses in this particular case, while effectively sparing the kidney.